Maternal High-fat Diet Accelerates Development of Crohn's Disease-like Ileitis in TNFΔARE/WT Offspring

Lisa Gruber1, Jana Hemmerling, Valentina Schüppel

  • 1*Technische Universität München, Chair of Nutrition and Immunology, Munich, Germany; †ZIEL-Institute for Food & Health, Technische Universität München, Munich, Germany; ‡Norwich Medical School, University of East Anglia, Norwich, United Kingdom; and §Nutrition, Metabolism and Genomics Group, Division of Human Nutrition, Wageningen University, Wageningen, the Netherlands.

Insights

Maternal high-fat diet (HFD) exacerbates Crohn's disease-like ileitis in genetically susceptible offspring. This effect occurs early in life and is independent of metabolic changes, highlighting the impact of prenatal nutrition on inflammatory conditions.

Area of Science:

  • Gastroenterology
  • Immunology
  • Nutritional Science

Background:

  • Maternal high-fat diet (HFD) and obesity are linked to increased offspring risk of inflammatory conditions, particularly in the gut.
  • Genetically driven Crohn's disease (CD)-like ileitis models are crucial for understanding disease pathogenesis.
  • Prenatal exposure to maternal obesity may program the fetal gut for inflammation.

Purpose of the Study:

  • To investigate if maternal diet-induced obesity programs the fetal gut towards inflammation.
  • To assess the impact of maternal HFD on the development of CD-like ileitis in offspring.
  • To determine the role of prenatal gene expression in the offspring's susceptibility to inflammation.

Main Methods:

  • Utilized TNF(WT/WT) and TNF(ΔARE/WT) mouse models, feeding dams control or HFD.
  • Assessed offspring ileitis severity, histopathology, inflammation markers, and plasma cytokines/LPS.
  • Analyzed fetal intestinal epithelial cell gene expression via microarrays.

Main Results:

  • Maternal HFD accelerated CD-like ileitis in HFD-fed ARE offspring, marked by increased neutrophil infiltration and LPS levels.
  • Offspring metabolic characteristics were unaffected by maternal HFD in contrast to WT mice.
  • Fetal gene expression in ARE mice showed minimal changes, indicating inflammation onset is independent of prenatal gut programming.

Conclusions:

  • Maternal HFD promotes early-onset, severe CD-like ileitis in genetically susceptible offspring.
  • The observed inflammation is independent of metabolic alterations in the offspring.
  • Prenatal nutritional environment significantly influences the development of inflammatory bowel disease phenotypes.
Abstract

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
764
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K